Amgen 4Q Revenues: $3.3 billion (+12%) 4Q Earnings: $928 million (+24%) FY Revenues: $12.4 billion (+18%) FY Earnings: $4 billion (+28%) Comments: Worldwide sales of Aranesp increased 24% to $873 million in the quarter and sales for the year were $3.3 billion, up 32%. Sales of Neulasta and Neupogen were $928 million in the quarter, an increase of 19% and sales were $3.5 billion for the year, up 20%. Enbrel sales were up 19% for the quarter to $674 million and sales increased ...